MATEON THERAPEUTICS INC Contracts & Agreements

232 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Term Sheet Between Mosaic ImmunoEngineering, Inc. and Oncotelic Therapeutics, Inc. Extending Expiration Date
Modification Agreements
MATEON THERAPEUTICS INC
Biotechnology
2025
Binding Term Sheet and Letter Agreement for Asset Acquisition between Mosaic ImmunoEngineering, Inc. and Oncotelic Therapeutics, Inc.
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
2024
Oncotelic Therapeutics, Inc. Subscription Agreement and Investment Letter with J.H. Darbie & Co., Inc.
Subscription Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2023
Oncotelic Therapeutics, Inc. Common Stock Purchase Warrant Agreement (2023)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2023
Oncotelic Therapeutics, Inc. 16% Convertible Unsecured Note Agreement (2023-2025)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2023
Registration Rights Agreement between Oncotelic Therapeutics, Inc. and Purchasers
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2023
Unsecured Convertible Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2022
Unsecured Convertible Promissory Note between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2022
Securities Purchase Agreement between Oncotelic Therapeutics, Inc. and Buyer (November 24, 2021)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
2021
Oncotelic Therapeutics, Inc. Convertible Promissory Note with Confession of Judgment Provision
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
2021
Unsecured Convertible Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC (October 25, 2021)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Unsecured Convertible Promissory Note between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC dated October 25, 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
License Agreement between Oncotelic Therapeutics, Inc. and Autotelic Inc. for Nasal Apomorphine Technology
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Unsecured Convertible Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Unsecured Convertible Promissory Note between Oncotelic Therapeutics, Inc. and Golden Mountain Partners, LLC dated September 21, 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Term Sheet for Licensing Agreement Between Oncotelic Therapeutics, Inc. and Autotelic Inc.
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
2021
Oncotelic Therapeutics, Inc. Convertible Promissory Note dated August 4, 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Note Purchase Agreement between Oncotelic Therapeutics, Inc. and Lenders (August 4, 2021)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Securities Purchase Agreement between Oncotelic Therapeutics, Inc. and Geneva Roth Remark Holdings, Inc.
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2021
Convertible Promissory Note between Oncotelic Therapeutics, Inc. and Geneva Roth Remark Holdings, Inc. dated May 25, 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2021
Equity Purchase Agreement between Oncotelic Therapeutics, Inc. and Peak One Opportunity Fund, L.P.
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
FL
2021
Registration Rights Agreement between Oncotelic Therapeutics, Inc. and PEAK ONE OPPORTUNITY FUND, L.P.
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
FL
2021
Subscription Agreement and Investment Letter between Mateon Therapeutics, Inc. and Investor for Private Placement Units
Subscription Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Engagement Agreement for Private Placement Financing between Mateon Therapeutics, Inc. and J H Darbie & Co., Inc.
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2021
EdgePoint AI, Inc. Common Stock Purchase Warrant Agreement with Holder
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2021
Common Stock Purchase Warrant Agreement between Mateon Therapeutics, Inc. and Holder
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2021
Mateon Therapeutics, Inc. 16% Convertible Unsecured Note Agreement (2020 Offering)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2021
Loan, Secured Convertible Note Purchase, and Security Agreement between Mateon Therapeutics, Inc. and Golden Mountain Partners, LLC (June 27, 2020)
Loan Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Secured Convertible Promissory Note between Mateon Therapeutics, Inc. and Golden Mountain Partners, LLC dated June 27, 2020
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
License, Development and Commercialization Agreement between Windlas Biotech Private Limited and Mateon Therapeutics, Inc.
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Memorandum of Understanding Between Windlas Biotech Private Limited and Mateon Therapeutics, Inc. for Artemisinin Co-Development
MOUs
MATEON THERAPEUTICS INC
Biotechnology
2020
Subscription Agreement and Investment Letter between Mateon Therapeutics, Inc. and Investor for Private Placement of Units
Subscription Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Engagement Agreement for Private Placement Financing between Mateon Therapeutics, Inc. and J H Darbie & Co., Inc.
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2020
EdgePoint AI, Inc. Common Stock Purchase Warrant Agreement (August 7, 2020)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Mateon Therapeutics, Inc. Common Stock Purchase Warrant Agreement (August 7, 2020)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Mateon Therapeutics, Inc. 16% Convertible Unsecured Note Agreement with Payee
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Registration Rights Agreement between Mateon Therapeutics, Inc. and Purchasers (August 7, 2020)
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Mateon Therapeutics, Inc. Common Stock Purchase Warrant Agreement (July 23, 2020)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Mateon Therapeutics, Inc. 16% Convertible Unsecured Note Due 2021
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Registration Rights Agreement between Mateon Therapeutics, Inc. and Purchasers (July 23, 2020)
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Independent Consulting Agreement between Mateon Therapeutics, Inc. and Anthony Maida
Consulting Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Exclusive License Agreement between Oncotelic Inc. and Autotelic Bio for Trabedersen (OT-101) Combination Therapy
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2020
Supplement to Research and Services Agreement between Oncotelic, Inc., Mateon Therapeutics, Inc., and Golden Mountain Partners, LLC
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2020
Employment Agreement between Mateon Therapeutics, Inc. and Dr. Fatih Uckun (Chief Medical Officer)
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Investigational Product Supply and Use Authorization Agreement for OT-101 U.S. Expanded Access (WideTrial and Oncotelic)
Supply Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Data License Agreement for OT-101 U.S. Expanded Access Program between WideTrial Inc. and Oncotelic Inc.
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Agreement for Delivery and Licensed Use of WideTrial Bonus Dataset (Data License 2 Agreement) between WideTrial Inc. and Oncotelic Inc.
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Employment Agreement between Mateon Therapeutics, Inc. and Dr. Vuong Trieu (CEO) dated August 23, 2019
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Employment Agreement between Mateon Therapeutics, Inc. and Dr. Fatih Uckun (Chief Medical Officer) dated August 23, 2019
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Employment Agreement between Mateon Therapeutics, Inc. and Dr. Chulho Park (Chief Technology Officer) dated August 23, 2019
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Employment Agreement between Mateon Therapeutics, Inc. and Amit Shah (CFO) dated August 23, 2019
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Separation Agreement and Release between Matthew M. Loar and Mateon Therapeutics, Inc.
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Mateon Therapeutics, Inc. $200,000 Convertible Debenture Due April 2022 with Peak One Opportunity Fund, L.P.
Debenture Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Mateon Therapeutics, Inc. Convertible Debenture Due April 2022
Debenture Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Separation Agreement and Release between Dr. William D. Schwieterman and Mateon Therapeutics, Inc.
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Amendment No. 2 to Employment Agreement between Mateon Therapeutics, Inc. and Dr. William D. Schwieterman
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2017
Amendment No. 1 to Employment Agreement between Mateon Therapeutics, Inc. and Matthew M. Loar
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2017
Amendment No. 1 to Second Amended and Restated Employment Agreement between Mateon Therapeutics, Inc. and Dr. David J. Chaplin
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2017
Common Stock Purchase Warrant Agreement between Mateon Therapeutics, Inc. and Holder (2017)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2017
Second Amended and Restated Employment Agreement between Mateon Therapeutics, Inc. and Dr. David Chaplin
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2016
Mateon Therapeutics, Inc. Amended and Restated Director Compensation Policy (Effective October 25, 2016)
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2016
Employment Agreement between OXiGENE, Inc. and Dr. William Schwieterman (Chief Executive Officer)
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2015
Employment Agreement between OXiGENE, Inc. and Matthew M. Loar (Chief Financial Officer)
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2015
Amended and Restated Employment Agreement between OXiGENE, Inc. and Dr. David Chaplin
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2015
Separation Agreement and Release between OXiGENE, Inc. and Barbara Riching
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2015
Amendment No. 1 to Employment Agreement between OXiGENE, Inc. and Dr. William Schwieterman
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2015
Amendment No. 9 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2015
Amendment to Employment Agreement Between OXiGENE, Inc. and Barbara D. Riching
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Consulting Agreement between OXiGENE, Inc. and Tekgenics, Inc. (Effective July 21, 2014)
Consulting Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2014
Employment Agreement between OXiGENE, Inc. and Dr. David Chaplin (Chief Executive Officer)
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2014
Amendment No. 1 to Employment Agreement between OXiGENE, Inc. and Dr. David Chaplin
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Separation Agreement and Release between Dr. Peter J. Langecker and OXiGENE, Inc.
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2014
OXiGENE, Inc. Amended and Restated Director Compensation Policy
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Amendment No. 8 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2014
Fourth Amendment to Lease Agreement between DWF III Gateway, LLC and OXiGENE, Inc.
Lease Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
License Agreement between OXiGENE, Inc. and Angiogene Pharmaceuticals Ltd. (June 14, 2012)
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2014
Third Amendment to Lease Agreement between DWF III Gateway, LLC and OXiGENE, Inc.
Lease Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
Amendment No. 6 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2013
Consulting Services Exhibit B to Consulting Agreement between OXiGENE, Inc. and David Chaplin, Ph.D.
Consulting Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
Employment Agreement between OXiGENE, Inc. and Barbara Riching (Chief Financial Officer)
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
Consulting Agreement between OXiGENE, Inc. and David Chaplin, Ph.D.
Consulting Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2013
Indemnification Agreement between OXiGENE, Inc. and Directors and Executive Officers
Indemnification Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2012
OXiGENE, Inc. Interim Chief Financial Officer Employment Amendment Letter with Barbara D. Riching
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2012
OXiGENE, Inc. Offer Letter and Indemnification Agreement with David L. Johnson
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2012
Amended and Restated Employment Agreement between OXiGENE, Inc. and Dr. Peter Langecker
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2012
Amendment No. 5 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2011
OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2011
Amendment No. 4 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2011
Amendment No. 3 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2010
Employment Agreement between OXiGENE, Inc. and Dr. Peter Langecker dated June 10, 2009
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2009
Separation Agreement and General Release between OXiGENE, Inc. and Dr. Patricia Walicke dated June 10, 2009
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2009
Office Lease Agreement between King Waltham LLC and OXIGENE, Inc. dated April 21, 2009
Lease Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2009
409A Amendment to Employment Agreement between OXiGENE, Inc. and James B. Murphy
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2009
409A Amendment to Employment Agreement between OXiGENE, Inc. and Patricia Walicke
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2009
Amendment No. 2 to Employment Agreement between OXiGENE, Inc. and Dr. David Chaplin
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2009
Amendment No. 2 to Employment Agreement between OXiGENE, Inc. and James B. Murphy
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2009
Research and Development Agreement between OXiGENE, Inc. and Symphony ViDA Holdings LLC (October 1, 2008)
Collaboration Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2009
Amended and Restated Research and Development Agreement among OXiGENE, Inc., Symphony ViDA Holdings LLC, and Symphony ViDA, Inc.
Collaboration Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2009
Office Lease Agreement between Broadway 701 Gateway Fee LLC and OXiGENE, Inc. for 701 Gateway Boulevard, South San Francisco
Lease Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2009
Indemnification Agreement between OXiGENE, Inc. and Its Directors (2008)
Indemnification Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2008
OXiGENE, Inc. Amended and Restated Director Compensation Policy (Non-Employee Directors)
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2008
Technology License Agreement between OXiGENE, Inc. and Symphony ViDA Holdings LLC dated October 1, 2008
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2008
Novated and Restated Technology License Agreement among OXiGENE, Inc., Symphony ViDA, Inc., and Symphony ViDA Holdings LLC
License Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2008
Amendment No. 1 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company
Shareholders Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2008
Second Amendment to Lease Agreement between BP Prospect Place LLC and OXIGENE, INC.
Lease Agreements
MATEON THERAPEUTICS INC
Biotechnology
2006
OXiGENE, Inc. Incentive Stock Option Agreement under 2005 Stock Plan
Bonus & Incentive Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2006
Lease Modification Agreement No. 1 between The Realty Associates Fund III and OXiGENE, INC.
Lease Agreements
MATEON THERAPEUTICS INC
Biotechnology
2005
OXiGENE, Inc. Director Compensation Arrangements Effective July 7, 2005
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2005
OXiGENE, Inc. 2005 Named Executive Officer Compensation Arrangements
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2005
OXiGENE, Inc. Description of Director Compensation Arrangement
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2005
OXiGENE, Inc. 2004 Named Executive Officers Compensation Arrangements
Compensation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2005
Office Lease Agreement between The Realty Associates Fund III and OXiGENE, Inc. for 230 Third Avenue, Waltham, MA
Lease Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2004
Office Sublease Agreement between Schwartz Communications, Inc. and Oxigene, Inc. dated March 16, 2004
Lease Agreements
MATEON THERAPEUTICS INC
Biotechnology
2004
Expanded Access Program Master Services Agreement between Mateon Therapeutics Inc. and Impatients N.V.
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Statement of Work #1 under Expanded Access Program Master Services Agreement between Mateon Therapeutics, Inc. and Impatients N.V. (myTomorrows)
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Addendum #1 to Expanded Access Program Master Services Agreement between Mateon Therapeutics, Inc. and Impatients N.V. (myTomorrows)
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Data Processing Agreement between Mateon Therapeutics Inc. and Impatients N.V. (myTomorrows)
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Subscription Agreement and Investment Letter between Mateon Therapeutics, Inc. and Investors (July 23, 2020)
Subscription Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Engagement Agreement for Private Placement Financing between Mateon Therapeutics, Inc. and J H Darbie & Co., Inc.
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2020
EdgePoint AI, Inc. Common Stock Purchase Warrant Issued to Holder – July 23, 2020
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Paycheck Protection Program Promissory Note between Mateon Therapeutics, Inc. and Silicon Valley Bank
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
2020
Research and Services Agreement between Oncotelic, Inc. and Golden Mountain Partners, LLC (February 3, 2020)
Services Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2020
Mateon Therapeutics, Inc. Convertible Promissory Note Issued Under Note Purchase Agreement (November 23, 2019)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2019
Note Purchase Agreement between Mateon Therapeutics, Inc. and Lenders (November 2019)
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2019
Amendment No. 1 to Agreement and Plan of Merger among Mateon Therapeutics Inc., Paris Acquisition Corp., and PointR Data Inc.
Merger Agreements
MATEON THERAPEUTICS INC
Biotechnology
2019
Agreement and Plan of Merger among Mateon Therapeutics Inc., Paris Acquisition Corp., PointR Data Inc., and Securityholder Representative
Merger Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Convertible Promissory Note between Mateon Therapeutics, Inc. and Pointr Data Inc. dated July 22, 2019
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Note Purchase Agreement between Mateon Therapeutics, Inc. and Pointr Data Inc. dated July 22, 2019
Note Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2019
Amendment No. 1 to Securities Purchase Agreement between Mateon Therapeutics, Inc. and Peak One Opportunity Fund, L.P.
Modification Agreements
MATEON THERAPEUTICS INC
Biotechnology
2019
Contingent Value Rights Agreement among Mateon Therapeutics, Inc., Oncotelic, Inc., and Others, dated April 17, 2019
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Agreement and Plan of Merger among Mateon Therapeutics, Inc., Oncotelic Acquisition Corporation, and Oncotelic, Inc.
Merger Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Securities Purchase Agreement between Mateon Therapeutics, Inc. and Peak One Opportunity Fund, L.P.
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NV
2019
Securities Purchase Agreement between Mateon Therapeutics, Inc. and Buyers (April 2019)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NV
2019
Common Stock Warrant Agreement between Mateon Therapeutics, Inc. and Divine Capital Markets LLC (2018)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2018
Mateon Therapeutics, Inc. Common Stock Purchase Warrant Agreement
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2018
Mateon Therapeutics, Inc. Common Stock Purchase B Warrant Agreement (2018)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2018
Mateon Therapeutics, Inc. Subscription Agreement for Unit Offering with Divine Capital Markets LLC
Subscription Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2018
Registration Rights Agreement between Mateon Therapeutics, Inc. and Purchasers (April 12, 2018)
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2018
Placement Agent Engagement Letter between Mateon Therapeutics, Inc. and Divine Capital Markets LLC (February 7, 2018)
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2018
Securities Purchase Agreement between Mateon Therapeutics, Inc. and Purchasers (2017)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2017
Pre-Funded Common Stock Purchase Warrant Agreement between Mateon Therapeutics, Inc. and Holder (2017)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2017
Placement Agent Common Stock Purchase Warrant between Mateon Therapeutics, Inc. and Rodman & Renshaw (2017)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2017
Securities Purchase Agreement between Mateon Therapeutics, Inc. and Purchasers (2017)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2017
Exclusive Placement Agent and Advisory Agreement between Mateon Therapeutics, Inc. and Rodman & Renshaw (H.C. Wainwright & Co., LLC)
Underwriting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2017
Mateon Therapeutics, Inc. 2017 Equity Incentive Plan
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2017
Mateon Therapeutics, Inc. Non-Qualified Stock Option Agreement under 2017 Equity Incentive Plan
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2017
Amended and Restated Mateon Therapeutics, Inc. 2005 Stock Plan (as amended and restated January 12, 2017)
Stock Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2017
Mateon Therapeutics, Inc. 2015 Amended and Restated Equity Incentive Plan (as of January 12, 2017)
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2017
Mateon Therapeutics, Inc. Common Stock Certificate (Specimen)
Stock Agreements
MATEON THERAPEUTICS INC
Biotechnology
2016
OXiGENE, Inc. Stock Option Agreement under 2015 Equity Incentive Plan
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
CA
2015
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Holder (2015)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2015
Securities Purchase Agreement between OXiGENE, Inc. and Purchasers dated March 20, 2015
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2015
Amended and Restated Placement Agent Agreement between OXiGENE, Inc. and H.C. Wainwright & Co., LLC
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2014
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Holder (May 2014)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Securities Purchase Agreement between OXiGENE, Inc. and Purchasers (May 22, 2014)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2014
Registration Rights Agreement between OXiGENE, Inc. and Purchasers Dated May 22, 2014
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Amended and Restated Placement Agent Agreement between OXiGENE, Inc. and H.C. Wainwright & Co., LLC (February 2014)
Underwriting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2014
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Holder (February 2014)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Placement Agent
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Securities Purchase Agreement between OXiGENE, Inc. and Purchasers (February 12, 2014)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2014
OXiGENE, Inc. Form of Placement Agent Common Stock Purchase Warrant (2014)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Holder (2014)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Placement Agent (2014)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Holder (2014)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2014
Securities Purchase Agreement between OXiGENE, Inc. and Purchasers (January 2014)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2014
Amended and Restated Placement Agent Agreement between OXiGENE, Inc. and H.C. Wainwright & Co., LLC
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2013
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Holder (September 2013)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
Amendment No. 7 to Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company, LLC
Modification Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2013
Securities Purchase Agreement between OXiGENE, Inc. and Purchasers (September 18, 2013)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2013
Registration Rights Agreement between OXiGENE, Inc. and Purchasers (September 18, 2013)
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and H.C. Wainwright & Co., LLC (2013)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
OXiGENE, Inc. Stock Purchase Warrant Certificate (2013)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2013
Placement Agent Agreement between OXiGENE, Inc. and Dawson James Securities, Inc. (April 10, 2013)
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2013
Series A/B Common Stock Purchase Warrant Agreement between OXiGENE, Inc. and Holder (April 2013)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
Securities Purchase Agreement between OXiGENE, Inc. and Purchasers dated April 10, 2013
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2013
Registration Rights Agreement between OXiGENE, Inc. and Purchasers (April 10, 2013)
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
2013
Purchase Agreement between OXiGENE, Inc. and Lincoln Park Capital Fund, LLC (November 28, 2011)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2011
Registration Rights Agreement between OXiGENE, Inc. and Lincoln Park Capital Fund, LLC (November 28, 2011)
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2011
OXiGENE, Inc. Series E Warrant to Purchase Common Stock Agreement with Hudson Bay Master Fund Ltd. and Other Buyers
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2011
Warrant Exchange Agreement between OXiGENE, Inc. and Investor (January 18, 2011)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
2011
Voting Agreement between OXiGENE, Inc. and Symphony ViDA Holdings LLC
Voting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2011
At Market Issuance Sales Agreement between OXiGENE, Inc. and McNicoll, Lewis & Vlak LLC (July 21, 2010)
Equity Distribution Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
OXiGENE, Inc. Series D Warrant to Purchase Common Stock (March 26, 2010)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
Amendment and Exchange Agreement between OXiGENE, Inc. and Investor (March 25, 2010)
Exchange Agreements
MATEON THERAPEUTICS INC
Biotechnology
2010
Registration Rights Agreement between OXiGENE, Inc. and Buyers dated March 10, 2010
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
OXiGENE, Inc. Series A Warrant to Purchase Common Stock Agreement with Hudson Bay Fund, LP and Others (March 2010)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
Series B Warrant to Purchase Common Stock between OXiGENE, Inc. and Holder (March 11, 2010)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
Series C Warrant to Purchase Common Stock between OXiGENE, Inc. and Holder (March 2010)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
Series D Warrant to Purchase Common Stock between OXiGENE, Inc. and Investors (March 2010)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
Securities Purchase Agreement between OXiGENE, Inc. and Investors (March 10, 2010)
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
Voting Agreement between OXiGENE, Inc. and Symphony ViDA Holdings LLC (March 10, 2010)
Voting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2010
Amendment No. 1 to Common Stock Purchase Agreement between OXiGENE, Inc. and Kingsbridge Capital Limited
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
2010
Agreement and Plan of Merger among OXiGENE, Inc., OXiGENE Merger Sub, Inc., VaxGen, Inc., and Stockholder Representative (October 14, 2009)
Merger Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2009
Placement Agent Agreement between OXiGENE, Inc. and Lazard Capital Markets LLC and Merriman Curhan Ford & Co. dated July 15, 2009
Underwriting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2009
OXiGENE, Inc. Series I Warrant to Purchase Common Stock (Form of Five-Year Warrant Issued to Investors)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2009
OXiGENE, Inc. Series II Warrant to Purchase Common Stock Issued to Investors (July 15, 2009)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2009
Subscription Agreement between OXiGENE, Inc. and Investor for Purchase of Units
Subscription Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2009
Amended and Restated Purchase Option Agreement among OXiGENE, Inc., Symphony ViDA Holdings LLC, and Symphony ViDA, Inc. dated July 2, 2009
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2009
Amended and Restated Registration Rights Agreement between OXiGENE, Inc. and Symphony ViDA Holdings LLC
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
2009
Termination Agreement among OXiGENE, Inc., Symphony ViDA Holdings LLC, Symphony ViDA Investors LLC, and Symphony ViDA, Inc.
Termination Agreements
MATEON THERAPEUTICS INC
Biotechnology
2009
409A Amendment to Employment Agreement between OXiGENE, Inc. and Dr. David Chaplin
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2009
409A Amendment to Employment Agreement between OXiGENE, Inc. and John Kollins
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2009
Amendment No. 1 to Employment Agreement between OXiGENE, Inc. and John A. Kollins
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2008
Separation Agreement and General Release between OXiGENE, Inc. and Dr. Richard Chin dated October 22, 2008
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2008
Amendment No. 3 to Employment Agreement between OXiGENE, Inc. and Joel-Tomas Citron
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2008
Direct Investment Warrant Agreement between OXiGENE, Inc. and Symphony ViDA Holdings LLC (October 17, 2008)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2008
Stock and Warrant Purchase Agreement between OXiGENE, Inc. and Symphony ViDA Holdings LLC dated October 1, 2008
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2008
Purchase Option Agreement among OXiGENE, Inc., Symphony ViDA Holdings LLC, and Symphony ViDA, Inc. dated October 1, 2008
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2008
Registration Rights Agreement between OXiGENE, Inc. and Symphony ViDA Holdings LLC dated October 1, 2008
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
2008
Additional Funding Agreement among OXiGENE, Inc., Symphony ViDA Holdings LLC, Symphony ViDA Investors LLC, and Symphony ViDA, Inc. dated October 1, 2008
Funding Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2008
Warrant Agreement for Purchase of Common Stock between OXiGENE, Inc. and Kingsbridge Capital Limited (February 19, 2008)
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2008
Registration Rights Agreement between OXiGENE, Inc. and Kingsbridge Capital Limited dated February 19, 2008
Registration Rights Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2008
Common Stock Purchase Agreement between Kingsbridge Capital Limited and OXiGENE, Inc. dated February 19, 2008
Purchase Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2008
Separation Agreement between OXiGENE, Inc. and Peter Harris, M.D. dated August 31, 2007
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
2007
Employment Agreement between OXiGENE, Inc. and Patricia Walicke dated July 27, 2007
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2007
Amendment No. 2 to Employment Agreement between OXiGENE, Inc. and Joel-Tomas Citron
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2007
Employment Agreement between OXiGENE, Inc. and John Kollins
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2007
Amendment No. 1 to Employment Agreement between OXiGENE, Inc. and David Chaplin, Ph.D.
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2007
Separation Agreement between OXiGENE, Inc. and Scott L. Young dated December 4, 2006
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2007
Amendment No. 1 to Employment Agreement between OXiGENE, Inc. and Joel-Tomas Citron
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
2006
Employment Agreement between OXiGENE, Inc. and Richard Chin, dated June 29, 2006
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2006
Separation Agreement between Fred Driscoll and OXiGENE, Inc. dated June 29, 2006
Separation Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2006
Employment Agreement between OXiGENE, Inc. and Dr. Peter Harris dated April 25, 2006
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2006
OXiGENE, Inc. Non-Qualified Stock Option Agreement under 2005 Stock Plan
Warrant Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2006
OXiGENE, Inc. Restricted Stock Agreement under 2005 Stock Plan
Stock Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2006
Underwriting Agreement between OXiGENE, Inc. and Underwriters (SG Cowen & Co., LLC and Lazard Capital Markets LLC) dated December 14, 2005
Underwriting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2005
Stockholder Rights Agreement between OXiGENE, Inc. and American Stock Transfer & Trust Company (March 24, 2005)
Stock Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2005
Placement Agency Agreement between OXiGENE, Inc. and Legg Mason Wood Walker, Inc. and Lazard Freres & Co. LLC (March 3, 2005)
Stock Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2005
Employment Agreement between OXiGENE, Inc. and James B. Murphy (Vice President and CFO)
Employment Agreements
MATEON THERAPEUTICS INC
Biotechnology
MA
2004
Stock Pledge and Loan Agreement between Per-Olof Söderberg and OXiGENE, Inc. dated September 1, 1999
Pledge Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2004
Stock Pledge and Loan Agreement between Per-Olof Söderberg and OXiGENE, Inc. dated November 13, 2000
Pledge Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2004
Placement Agency Agreement between OXiGENE, Inc. and Lehman Brothers, Rodman & Renshaw, and Roth Capital Partners (January 13, 2004)
Underwriting Agreements
MATEON THERAPEUTICS INC
Biotechnology
NY
2004